LRRK2 Phosphorylation, More Than an Epiphenomenon

Antoine Marchand1,2, Matthieu Drouyer1,2, Alessia Sarchione1,2

  • 1University of Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille, France.

Insights

Leucine Rich Repeat Kinase 2 (LRRK2) gene mutations are linked to Parkinson's disease (PD). This review explores how LRRK2 phosphorylation impacts its function and cellular processes relevant to PD pathogenesis.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Mutations in the Leucine Rich Repeat Kinase 2 (LRRK2) gene are a known cause of autosomal dominant Parkinson's disease (PD).
  • Genetic variations in the LRRK2 gene are also associated with an increased risk for developing sporadic PD.
  • LRRK2 is a kinase that undergoes multiphosphorylation, crucial for its physiological and pathological functions.

Purpose of the Study:

  • To review current knowledge on Leucine Rich Repeat Kinase 2 (LRRK2) phosphorylation.
  • To discuss the regulatory mechanisms governing LRRK2 phosphorylation levels.
  • To explore how alterations in LRRK2 phosphorylation affect cellular processes implicated in Parkinson's disease.

Main Methods:

  • Literature review of existing research on LRRK2 phosphorylation.
  • Analysis of evidence linking LRRK2 phosphorylation status to PD pathology.
  • Synthesis of information on LRRK2 phosphoregulation and its cellular consequences.

Main Results:

  • Reduced LRRK2 heterologous phosphorylation is observed in PD brains and upon pharmacological LRRK2 inhibition.
  • Dephosphorylation of LRRK2 at heterologous phosphosites leads to its accumulation in subcellular compartments.
  • The precise regulatory mechanisms and full cellular consequences of LRRK2 phosphorylation changes are not yet fully understood.

Conclusions:

  • LRRK2 phosphorylation plays a critical role in both the normal function and the disease mechanisms of Parkinson's disease.
  • Further research into LRRK2 phosphoregulation is necessary to fully elucidate its connection to PD.
  • Understanding LRRK2 phosphorylation dynamics may reveal novel therapeutic targets for Parkinson's disease.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.0K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
14.5K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.2K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
17.3K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
16.6K
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
53.4K